Published in Nat Genet on November 01, 1997
New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet (2010) 17.89
Physiological significance of a peripheral tissue circadian clock. Proc Natl Acad Sci U S A (2008) 5.94
Sugar transporters for intercellular exchange and nutrition of pathogens. Nature (2010) 3.60
Tumor-induced osteomalacia. Endocr Relat Cancer (2011) 3.13
Crystal structure of a bacterial homologue of glucose transporters GLUT1-4. Nature (2012) 2.64
Nutrient-sensing mechanisms and pathways. Nature (2015) 2.46
Noninvasive in vivo monitoring of tissue-specific global gene expression in humans. Proc Natl Acad Sci U S A (2014) 2.07
The SLC2 (GLUT) family of membrane transporters. Mol Aspects Med (2013) 1.97
The glucose-6-phosphatase system. Biochem J (2002) 1.87
Glycogen storage diseases: new perspectives. World J Gastroenterol (2007) 1.67
Deletion of the von Hippel-Lindau gene in pancreatic beta cells impairs glucose homeostasis in mice. J Clin Invest (2008) 1.56
SLC2A2 mutations can cause neonatal diabetes, suggesting GLUT2 may have a role in human insulin secretion. Diabetologia (2012) 1.54
Neonatal diabetes: an expanding list of genes allows for improved diagnosis and treatment. Curr Diab Rep (2011) 1.52
Management of diabetes mellitus in infants. Nat Rev Endocrinol (2011) 1.40
Normal kinetics of intestinal glucose absorption in the absence of GLUT2: evidence for a transport pathway requiring glucose phosphorylation and transfer into the endoplasmic reticulum. Proc Natl Acad Sci U S A (2001) 1.39
Normal hepatic glucose production in the absence of GLUT2 reveals an alternative pathway for glucose release from hepatocytes. Proc Natl Acad Sci U S A (1998) 1.30
The role of fructose transporters in diseases linked to excessive fructose intake. J Physiol (2012) 1.21
Crystal structure of a glucose/H+ symporter and its mechanism of action. Proc Natl Acad Sci U S A (2013) 1.19
Modeling of environmental effects in genome-wide association studies identifies SLC2A2 and HP as novel loci influencing serum cholesterol levels. PLoS Genet (2010) 1.10
Familial renal glucosuria: a clinicogenetic study of 23 additional cases. Pediatr Nephrol (2012) 0.95
The molecular and genetic base of congenital transport defects. Gut (2000) 0.93
Homozygous haplotype deficiency reveals deleterious mutations compromising reproductive and rearing success in cattle. BMC Genomics (2015) 0.90
Many faces of monogenic diabetes. J Diabetes Investig (2014) 0.89
GLUT, SGLT, and SWEET: Structural and mechanistic investigations of the glucose transporters. Protein Sci (2016) 0.87
Fanconi-Bickel syndrome--a congenital defect of the liver-type facilitative glucose transporter. SSIEM Award. Society for the Study of Inborn Errors of Metabolism. J Inherit Metab Dis (1998) 0.86
No mutation in the SLC2A2 ( GLUT2) gene in a Turkish infant with Fanconi-Bickel syndrome. Pediatr Nephrol (2003) 0.86
A secondary respiratory chain defect in a patient with Fanconi-Bickel syndrome. J Inherit Metab Dis (2002) 0.84
Monogenic models: what have the single gene disorders taught us? Curr Diab Rep (2012) 0.83
Phenotypic variability in patients with fanconi-bickel syndrome with identical mutations. JIMD Rep (2014) 0.82
Making sense of glucose sensing. Nat Genet (1997) 0.81
Insights from genetic disorders of phosphate homeostasis. Semin Nephrol (2013) 0.81
Fanconi Bickel Syndrome: Novel Mutations in GLUT 2 Gene Causing a Distinguished Form of Renal Tubular Acidosis in Two Unrelated Egyptian Families. Case Rep Nephrol (2011) 0.81
Inherited epithelial transporter disorders--an overview. J Inherit Metab Dis (2008) 0.81
Identification of a novel mutation in the GLUT2 gene in a patient with Fanconi-Bickel syndrome presenting with neonatal diabetes mellitus and galactosaemia. Eur J Pediatr (2002) 0.80
Fanconi-Bickel syndrome - mutation in SLC2A2 gene. Indian J Pediatr (2014) 0.79
Molecular developments in renal tubulopathies. Arch Dis Child (2000) 0.79
Positron emission tomography probe demonstrates a striking concentration of ribose salvage in the liver. Proc Natl Acad Sci U S A (2014) 0.79
Monogenic Diabetes: What It Teaches Us on the Common Forms of Type 1 and Type 2 Diabetes. Endocr Rev (2016) 0.78
Fanconi-Bickel syndrome as an example of marked allelic heterogeneity. World J Nephrol (2012) 0.78
What's new in metabolic and genetic hypoglycaemias: diagnosis and management. Eur J Pediatr (2007) 0.78
Genetic variation of fasting glucose and changes in glycemia in response to 2-year weight-loss diet intervention: the POUNDS LOST trial. Int J Obes (Lond) (2016) 0.77
Fanconi-Bickel syndrome versus osteogenesis imperfeeta: An Iranian case with a novel mutation in glucose transporter 2 gene, and review of literature. Indian J Hum Genet (2013) 0.77
Impact of genetic polymorphisms of SLC2A2, SLC2A5, and KHK on metabolic phenotypes in hypertensive individuals. PLoS One (2013) 0.77
Genetic hypoglycaemia in infancy and childhood: pathophysiology and diagnosis. J Inherit Metab Dis (2000) 0.76
Mutation analysis of the GLUT2 gene in three unrelated Egyptian families with Fanconi-Bickel syndrome: revisited gene atlas for renumbering. Clin Exp Nephrol (2012) 0.76
Fanconi-Bickel Syndrome: Two Pakistani Patients Presenting with Hypophosphatemic Rickets. J Pediatr Genet (2016) 0.75
Molecular spectrum and differential diagnosis in patients referred with sporadic or autosomal recessive osteogenesis imperfecta. Mol Genet Genomic Med (2016) 0.75
Fanconi-Bickel syndrome and autosomal recessive proximal tubulopathy with hypercalciuria (ARPTH) are allelic variants caused by GLUT2 mutations. J Clin Endocrinol Metab (2012) 0.75
EsGLUT4 and CHHBP are involved in the regulation of glucose homeostasis in the crustacean Eriocheir sinensis. Biol Open (2017) 0.75
LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell (2001) 11.99
Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK). Am J Med Genet (1998) 7.68
Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor. J Thromb Haemost (2006) 4.58
Mutations in the human Ca(2+)-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell (1993) 4.13
A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD). J Thromb Haemost (2006) 2.56
Homozygosity mapping of the gene for alkaptonuria to chromosome 3q2. Nat Genet (1993) 2.44
Pyridoxal 5'-phosphate may be curative in early-onset epileptic encephalopathy. J Inherit Metab Dis (2006) 1.98
Genetic linkage of the Marfan syndrome, ectopia lentis, and congenital contractural arachnodactyly to the fibrillin genes on chromosomes 15 and 5. The International Marfan Syndrome Collaborative Study. N Engl J Med (1992) 1.95
Osteoporosis-pseudoglioma syndrome, a disorder affecting skeletal strength and vision, is assigned to chromosome region 11q12-13. Am J Hum Genet (1996) 1.89
Ehlers-Danlos syndrome type IV: a multi-exon deletion in one of the two COL3A1 alleles affecting structure, stability, and processing of type III procollagen. J Biol Chem (1988) 1.88
Cysteine in the triple-helical domain of one allelic product of the alpha 1(I) gene of type I collagen produces a lethal form of osteogenesis imperfecta. J Biol Chem (1984) 1.84
Identification of a mutation that causes exon skipping during collagen pre-mRNA splicing in an Ehlers-Danlos syndrome variant. J Biol Chem (1988) 1.83
Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD). J Thromb Haemost (2008) 1.81
Evidence for a structural mutation of procollagen type I in a patient with the Ehlers-Danlos syndrome type VII. J Biol Chem (1980) 1.69
Discovery of novel antifungal (1,3)-beta-D-glucan synthase inhibitors. Antimicrob Agents Chemother (2000) 1.66
In vitro and in vivo estrogenicity of UV screens. Environ Health Perspect (2001) 1.65
Lethal osteogenesis imperfecta resulting from a single nucleotide change in one human pro alpha 1(I) collagen allele. Proc Natl Acad Sci U S A (1986) 1.65
Remission of thrombotic thrombocytopenic purpura in a patient with compound heterozygous deficiency of von Willebrand factor-cleaving protease by infusion of solvent/detergent plasma. Acta Paediatr (2002) 1.64
Resistance to activated protein C (APCR) in children with venous or arterial thromboembolism. Br J Haematol (1996) 1.61
Osteogenesis imperfecta: update and perspective. Am J Med Genet (1984) 1.60
Genetic counselling on brittle grounds: recurring osteogenesis imperfecta due to parental mosaicism for a dominant mutation. Eur J Pediatr (1995) 1.57
An Alu-mediated novel large deletion is the most frequent cause of type 3 von Willebrand disease in Hungary. J Thromb Haemost (2008) 1.51
Nonketotic hyperglycinemia: clinical and electrophysiologic effects of dextromethorphan, an antagonist of the NMDA receptor. Neurology (1993) 1.51
Missense mutations associated with RFLP haplotypes 1 and 4 of the human phenylalanine hydroxylase gene. Am J Hum Genet (1990) 1.45
Fanconi-Bickel syndrome--a congenital defect of facilitative glucose transport. Curr Mol Med (2002) 1.45
Achondrogenesis type IB is caused by mutations in the diastrophic dysplasia sulphate transporter gene. Nat Genet (1996) 1.44
Temperature-dependent expression of a collagen splicing defect in the fibroblasts of a patient with Ehlers-Danlos syndrome type VII. J Biol Chem (1989) 1.40
Urinary pyridinoline cross-links in Ehlers-Danlos syndrome type VI. Am J Hum Genet (1995) 1.39
Abnormal collagen fibril structure in the gravis form (type I) of Ehlers-Danlos syndrome. Lab Invest (1979) 1.36
Delayed triple helix formation of mutant collagen from patients with osteogenesis imperfecta. J Mol Biol (1994) 1.36
Marfan syndrome: no evidence for heterogeneity in different populations, and more precise mapping of the gene. Am J Hum Genet (1991) 1.35
Shear-induced unfolding activates von Willebrand factor A2 domain for proteolysis. J Thromb Haemost (2009) 1.33
Recessively inherited multiple epiphyseal dysplasia with normal stature, club foot, and double layered patella caused by a DTDST mutation. J Med Genet (1999) 1.29
The diagnosis of hereditary fructose intolerance. Helv Paediatr Acta (1981) 1.27
G to T transversion at position +5 of a splice donor site causes skipping of the preceding exon in the type III procollagen transcripts of a patient with Ehlers-Danlos syndrome type IV. J Biol Chem (1991) 1.27
Molecular defects of type III procollagen in Ehlers-Danlos syndrome type IV. Hum Genet (1989) 1.24
Infantile systemic hyalinosis in siblings: clinical report, biochemical and ultrastructural findings, and review of the literature. Am J Med Genet (2001) 1.21
A homozygous stop codon in the lysyl hydroxylase gene in two siblings with Ehlers-Danlos syndrome type VI. Nat Genet (1992) 1.20
Fanconi-Bickel syndrome--the original patient and his natural history, historical steps leading to the primary defect, and a review of the literature. Eur J Pediatr (1998) 1.18
Haplotype distribution of the human phenylalanine hydroxylase locus in Scotland and Switzerland. Am J Hum Genet (1989) 1.17
The neonatal pseudo-hydrocephalic progeroid syndrome (Wiedemann-Rautenstrauch). Report of a new patient and review of the literature. Eur J Pediatr (1988) 1.15
Linkage analysis in families diagnosed with type 1 von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 VWD. J Thromb Haemost (2006) 1.14
Characterization of a large deletion associated with a polymorphic block of repeated dinucleotides in the type III procollagen gene (COL3A1) of a patient with Ehlers-Danlos syndrome type IV. Am J Hum Genet (1991) 1.14
Expression of 14 von Willebrand factor mutations identified in patients with type 1 von Willebrand disease from the MCMDM-1VWD study. J Thromb Haemost (2009) 1.13
Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Effects of mutant gene dosage on phenotype. J Clin Invest (1994) 1.13
Uridine diphosphate galactose 4-epimerase deficiency. II. Clinical follow-up, biochemical studies and family investigation. Helv Paediatr Acta (1973) 1.12
COL5A1 haploinsufficiency is a common molecular mechanism underlying the classical form of EDS. Am J Hum Genet (2000) 1.12
Hospital anxiety and depression scale cutoff scores for cancer patients in acute care. Br J Cancer (2009) 1.11
Demonstration of an inactive enzyme antigen in sucrase-isomaltase deficiency. Helv Paediatr Acta (1973) 1.11
Clinical variability of osteogenesis imperfecta reflecting molecular heterogeneity: cysteine substitutions in the alpha 1(I) collagen chain producing lethal and mild forms. J Biol Chem (1986) 1.11
Proteoglycan sulfation in cartilage and cell cultures from patients with sulfate transporter chondrodysplasias: relationship to clinical severity and indications on the role of intracellular sulfate production. Matrix Biol (1998) 1.10
Impaired secretion of type III procollagen in Ehlers-Danlos syndrome type IV fibroblasts: correction of the defect by incubation at reduced temperature and demonstration of subtle alterations in the triple-helical region of the molecule. Biochem Biophys Res Commun (1988) 1.09
Ehlers-Danlos syndrome in two siblings with deficient lysyl hydroxylase activity in cultured skin fibroblasts but only mild hydroxylysine deficit in skin. Helv Paediatr Acta (1975) 1.09
Zurich Fabry study - prevalence of Fabry disease in young patients with first cryptogenic ischaemic stroke or TIA. Eur J Neurol (2012) 1.09
Molecular basis of essential fructosuria: molecular cloning and mutational analysis of human ketohexokinase (fructokinase). Hum Mol Genet (1994) 1.07
A rare branch-point mutation is associated with missplicing of fibrillin-2 in a large family with congenital contractural arachnodactyly. Am J Hum Genet (1997) 1.07
Ehlers-Danlos syndrome type VIIB. Deletion of 18 amino acids comprising the N-telopeptide region of a pro-alpha 2(I) chain. J Biol Chem (1987) 1.06
Galactosemia: how does long-term treatment change the outcome? Enzyme (1984) 1.06
Multiple acyl-Co A dehydrogenation deficiency (MADD) in a boy with nonketotic hypoglycemia, hepatomegaly, muscle hypotonia and cardiomyopathy. Detection of N-isovalerylglutamic acid and its monoamide. Helv Paediatr Acta (1983) 1.05
Role of bile acids in the activation of trypsinogen by enterokinase: disturbance of trypsinogen activation in patients with intrahepatic biliary atresia. Gastroenterology (1974) 1.04
Osteoporosis-pseudoglioma or osteogenesis imperfecta? Clin Genet (1986) 1.04
Ehlers-Danlos syndrome type VIIB. Morphology of type I collagen fibrils formed in vivo and in vitro is determined by the conformation of the retained N-propeptide. J Biol Chem (1993) 1.04
Heterogeneity in Schwartz-Jampel chondrodystrophic myotonia. Eur J Pediatr (1997) 1.03
Longitudinal manganese and copper balances in young infants and preterm infants fed on breast-milk and adapted cow's milk formulas. Br J Nutr (1989) 1.03
In vivo studies of the phenylalanine-4-hydroxylase system in hyperphenylalaninemics and phenylketonurics. Helv Paediatr Acta (1978) 1.02
Excretion of pterins in phenylketonuria and phenylketonuria variants. Helv Paediatr Acta (1980) 1.02
A HaeIII RFLP in COL1A1. Nucleic Acids Res (1990) 1.02
Catalytically inactive sucrase antigen of rabbit small intestine: the enzyme precursor. Helv Paediatr Acta (1975) 1.02
Diagnosis of Pompe's disease using leukocyte preparations. Kinetic and immunological studies of 1,4-alpha-glucosidase in human fetal and adult tissues and cultured cells. Clin Chim Acta (1985) 1.01
Ehlers-Danlos syndrome type VII: clinical features and molecular defects. J Bone Joint Surg Am (1999) 1.01
Schwartz-Jampel syndrome type 2 and Stüve-Wiedemann syndrome: a case for "lumping". Am J Med Genet (1998) 1.01
Iron balances in infant nutrition. Acta Paediatr Scand (1987) 1.00
Decreased extracellular deposition of fibrillin and decorin in neonatal Marfan syndrome fibroblasts. Hum Genet (1993) 1.00
Mutations and phenotype in isolated glycerol kinase deficiency. Am J Hum Genet (1996) 0.99
Pseudohypoparathyroidism and hypocalcemic "myopathy". A case report. Klin Wochenschr (1981) 0.99
Luminographic detection of von Willebrand factor multimers in agarose gels and on nitrocellulose membranes. Thromb Haemost (1990) 0.99
Molecular nosology of heritable disorders of connective tissue. Am J Med Genet (1992) 0.98
Prenatal diagnosis of hereditary tyrosinemia by determination of fumarylacetoacetase in cultured amniotic fluid cells. Pediatr Res (1985) 0.98
Atypical phenylketonuria caused by 7, 8-dihydrobiopterin synthetase deficiency. Lancet (1979) 0.98
Molecular genetic basis and prevalence of glycogen storage disease type IIIA in the Faroe Islands. Eur J Hum Genet (2001) 0.98
Cross-linking of the dermo-epidermal junction of skin regenerating from keratinocyte autografts. Anchoring fibrils are a target for tissue transglutaminase. J Clin Invest (1996) 0.98
Primary sclerosing cholangitis in children. J Pediatr Gastroenterol Nutr (1988) 0.98
Agarose gel isoelectrofocusing of UDP-galactose pyrophosphorylase and galactose-1-phosphate uridyltransferase. Developmental aspect of UDP-galactose pyrophosphorylase. Clin Chim Acta (1987) 0.97
Pearson bone marrow-pancreas syndrome with insulin-dependent diabetes, progressive renal tubulopathy, organic aciduria and elevated fetal haemoglobin caused by deletion and duplication of mitochondrial DNA. Eur J Pediatr (1993) 0.97
Glycogen storage disease type Ib. Eur J Pediatr (1983) 0.95
Successful treatment of Pseudomonas aeruginosa respiratory tract infection with a sugar solution--a case report on a lectin based therapeutic principle. Klin Padiatr (2001) 0.95
Atypical phenylketonuria due to tetrahydrobiopterin deficiency. Diagnosis and treatment with tetrahydrobiopterin, dihydrobiopterin and sepiapterin. Clin Chim Acta (1979) 0.95
Decreased plasma concentration of von Willebrand factor antigen (VWF:Ag) in patients with glycogen storage disease type Ia. J Inherit Metab Dis (2005) 0.95
Genetic defects in von Willebrand disease type 3 in Indian and Greek patients. Blood Cells Mol Dis (2008) 0.95
Rubella embryopathy after previous maternal rubella vaccination. Infection (1984) 0.95
The structure of human collagen type IX and its organization in fetal and infant cartilage fibrils. J Biol Chem (1988) 0.95
Laboratory signs of activated coagulation are common in Henoch-Schönlein purpura. Pediatr Nephrol (2001) 0.95
Hormone-elicited enzyme release by the small intestinal wall. Gut (1972) 0.94
Mechanism of action of FK 506 and cyclosporin. Lancet (1991) 0.94
Prevalence of factor V Leiden in children with thrombo-embolism. Eur J Pediatr (1996) 0.94